会社概要

Takashi Nonogaki, Chairman of the Board Director
Chairman of the Board Director
Takashi Nonogaki

Takahiko Nonogaki, Chief Executive Officer
Chief Executive Officer
Takahiko Nonogaki

Establishment October 1972 (Founded Meiji 40)
Representative Takahiko Nonogaki
Capital 48,000 thousand yen
Businesses
  • Manufacture and sales of honey, royal jelly and other bee products, health foods, and pharmaceuticals
  • Apiculture training and sales of apiculture equipment
  • Study on health food
Number of employees

1,641名(2023年8月末)

Recent achievements 【2023年8月期】
売上高 46,183百万円・経常利益 3,254百万円
Banks

十六銀行本店、大垣共立銀行岐阜支店、三菱UFJ銀行岐阜支店、三井住友銀行新橋支店、みずほ銀行名古屋中央支店

Affiliated Companies

Gifu Yoho Co., Ltd., API Holdings Co., Ltd., API (SHANGHAI) Trading Co., LTD., UNIGEN Inc

 

会社紹介映像

オリジナル版(11:17)

ダイジェスト版(2:58)

Api's Wish

願いはひとつ
「人々の健康に貢献したい」
そのためにアピは挑戦し続けます。
Api's corporate philosophy is "creating a health and fulfilling lifestyle through honeybees". Under this philosophy, our company has been in business for over 110 years since the establishment in 1907.
In 1994, we made a full-scale entry into the field of health supplements from the beekeeping industry, and as a health food OEM maker, have responded to the diverse needs of many customers. In 2004, we made a foray into contract manufacturing of pharmaceuticals. In 2013, we launched the Ikeda Bio pharmaceutical Factory, which enables us to supply the next generation of superior bio pharmaceuticals. At present, we are working on this pharmaceuticals business to expand like our health supplement business.
Medical care, nursing care and welfare are becoming increasingly important in the modern age of a super-aging society. People's wish is to live long and healthy, and at the same time it is our desire to contribute to people's health.
In our dietary supplement business, we have a desire to provide a total of marketing, material development, planning, development, technology, manufacturing and reliable quality with original ideas. Under this desire, we are developing "API's ODM" that further refines the concept of ODM, utilizing the know-how cultivated through OEM. In the pharmaceuticals business, we have always taken on new challenges since our founding, such as by grouping UNIGEN Co., Ltd., which has unique technologies and production capabilities in the manufacture of biopharmaceutical drug substances.
There are still many hurdles to overcome, but we will continue to challenge boldly without fear of change in order to remain a company that can meet the expectations of our customers.
API Co., Ltd.
Takahiko Nonogaki, Chief Executive Officer

Contact
inquiry

Please feel free to contact us for any inquiries!